Neutrophil Phenotyping: A Novel Microdevice for Rapid Neutrophil Purification and Phenotyping in Type 2 Diabetes Mellitus (Small 6/2018)

By  

SMALL, Vol. 14, Iss. 6, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel pyridine‐2,4,6‐tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type‐2 diabetes mellitus: In vitro studies against yeast α‐ and β‐glucosidase and in silico molecular modeling

By  

ARCHIV DER PHARMAZIE (ELECTRONIC), Vol. 351, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of rheograms of the blood of patients with myocardial ischemia and type-2 diabetes mellitus with the use of a new model in the process of pharmaceutical therapy

By Yamaikina I.   Tagkhizadekh G.   Mit’kovskaya N.  

Journal of Engineering Physics and Thermophysics, Vol. 78, Iss. 5, 2005-09 ,pp. : 1029-1033

Springer Publishing Company

Access to resources Recommend Favorite

CE‐MS‐based serum fingerprinting to track evolution of type 2 diabetes mellitus

By  

ELECTROPHORESIS, Vol. 36, Iss. 18, 2015-09 ,pp. : 2286-2293

John Wiley & Sons Inc

Access to resources Recommend Favorite

Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges

By  

MEDICINAL RESEARCH REVIEWS, Vol. 38, Iss. 2, 2018-03 ,pp. : 381-425

John Wiley & Sons Inc

Access to resources Recommend Favorite